2022 annual financial data
TScan Therapeutics 2022 Operating margin
TScan Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -492.32%.
Operating income was -66,636,000 USD and net income was -66,221,000 USD.
Operating cash flow was -66,503,000 USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,535,000 USD
- Operating income
- -66,636,000 USD
- Net income
- -66,221,000 USD
- Operating cash flow
- -66,503,000 USD